Initial Regimen
385 results
146 - 245Abacavir
Abacavir
Rifabutin
Brucella Species
Rifabutin
Pneumonia, Community-Acquired (Adult)
HIV, Occupational Exposure
Diabetic Ketoacidosis
HIV, Occupational Exposure
Mycobacterium abscessus
Nelfinavir
Nelfinavir
Resistance testing: genotype
Retroviral Syndrome, Acute
Retroviral Syndrome, Acute
Tropheryma whipplei
Insulins (Bolus): Rapid- and Short-acting
Onchocerciasis
Hepatic Abscess
Staphylococcus spp.
Furuncle/Carbuncle
Para-aminosalicylic acid [PAS]
Salmonella spp.
Epidural Abscess
Acanthamoeba
Doripenem
Atazanavir
Atazanavir
Helicobacter pylori
Cryptococcal Meningitis
Children and Type 2 Diabetes
Septic Arthritis (Native)
Lenacapavir
Imipenem/Cilastatin
JC Virus
Post-exposure prophylaxis
When to Start Therapy: Chronic HIV Infection
Antiretroviral Therapy: Treatment-Experienced Patients
Cryptococcus
BK Virus
Candida albicans
Anthrax vaccine
Lyme Disease
Toxoplasma gondii
Anthrax vaccine
Menopausal Effects on Glycemia
Post-Pancreatectomy Diabetes
Vaginal Discharge
Type 2 Diabetes: Sequencing Therapies
Leishmania species
Monitoring Therapy
Erythropoietin
Exercise Interventions for Mental Health
Lopinavir/ritonavir
Lopinavir/ritonavir
Tuberculosis, Active
Clostridioides (ex. Clostridium) difficile
Streptococcus pneumoniae
Sofosbuvir + Ledipasvir
Sofosbuvir + Ledipasvir
Enterococcus
Herpes Simplex Virus
Levofloxacin
Levofloxacin
Fever in the returned traveler from tropical areas
Human papillomavirus (HPV)
Preventing HIV in 2025: Primary Care and Psychiatry at the Forefront of Prep
Ganciclovir
Ganciclovir
Telaprevir
Telaprevir
Skin conditions in the returned traveler
Pyelonephritis, Acute, Uncomplicated
Staphylococcus aureus
Impetigo
Anthrax, Pre-exposure and Post-Exposure Prevention
Toxicity & side effects: switching therapy
Appendicitis
Insulin Pump Management
Ibrexafungerp
Moxifloxacin
Moxifloxacin
Genital Ulcer Adenopathy Syndromes
Efavirenz
Efavirenz
Aging and HIV
Ciprofloxacin
Ciprofloxacin
Ribavirin
Sertraline
Delirium